In cervical cancer, DARS-AS1 exhibits pro-tumorigenic effects by activating the Notch pathway 33, and cGMP-PKG pathway 37, exacerbating the tumorigenesis of cervical cancer. This evidence concerns the gene DARS1 and cervical cancer.